Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Higher-risk Myelodysplastic Syndrome × Azacitidine × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 38 Myelodysplastic Syndromes 4 Leukemia, Myelomonocytic, Chronic 4 Leukemia 4 Recurrence 2 Pathologic Complete Response 2 Neoplasms 2 MDS 1 Lymphoma, T-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Leukemia, Myeloid 1 Higher-risk Myelodysplastic Syndrome 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

luspatercept 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06927232 2025-04-15

AZA+Lus VS AZA Monotherapy in HR-MDS

Peking Union Medical College Hospital

Phase 3 Not yet recruiting

Higher-risk Myelodysplastic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡